Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
Therapeutic strategies targeting B-cells in multiple sclerosis.
Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
Multiple sclerosis: Gene-vitamin D interactions likely to influence pathogenesis and risk of relapse in multiple sclerosis.
Brain radiation and possible presentation of multiple sclerosis.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Interventions for children coping with parental multiple sclerosis: A systematic review.
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
[Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum].
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Patient assessment within the context of healthcare delivery packages: A comparative analysis.
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.
Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Month of birth and risk of multiple sclerosis: confounding and adjustments.
Pages
« first
‹ previous
…
590
591
592
593
594
595
596
597
598
…
next ›
last »